FRESENIUS SE & CO KGAA (FRE.DE) Stock Fundamental Analysis
FRA:FRE - Deutsche Boerse Ag - DE0005785604 - Common Stock - Currency: EUR
FRE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 24 industry peers in the Health Care Providers & Services industry. FRE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. FRE is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year FRE was profitable.
In the past year FRE had a positive cash flow from operations.
FRE had positive earnings in 4 of the past 5 years.
FRE had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
FRE has a worse Return On Assets (1.08%) than 60.87% of its industry peers.
FRE has a worse Return On Equity (2.41%) than 60.87% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.58%, FRE is in line with its industry, outperforming 47.83% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.08% | ||
| ROE | 2.41% | ||
| ROIC | 2.58% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Profit Margin value of 2.16%, FRE perfoms like the industry average, outperforming 47.83% of the companies in the same industry.
FRE's Profit Margin has declined in the last couple of years.
FRE has a better Operating Margin (8.18%) than 78.26% of its industry peers.
FRE's Operating Margin has declined in the last couple of years.
FRE has a Gross Margin of 24.63%. This is comparable to the rest of the industry: FRE outperforms 52.17% of its industry peers.
FRE's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.18% | ||
| PM (TTM) | 2.16% | ||
| GM | 24.63% |
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FRE is destroying value.
Compared to 1 year ago, FRE has about the same amount of shares outstanding.
FRE has more shares outstanding than it did 5 years ago.
FRE has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 1.85 indicates that FRE is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of FRE (1.85) is better than 60.87% of its industry peers.
The Debt to FCF ratio of FRE is 9.10, which is on the high side as it means it would take FRE, 9.10 years of fcf income to pay off all of its debts.
FRE has a Debt to FCF ratio of 9.10. This is comparable to the rest of the industry: FRE outperforms 52.17% of its industry peers.
FRE has a Debt/Equity ratio of 0.55. This is a neutral value indicating FRE is somewhat dependend on debt financing.
FRE has a better Debt to Equity ratio (0.55) than 86.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 9.1 | ||
| Altman-Z | 1.85 |
ROIC/WACC0.35
WACC7.39%
2.3 Liquidity
A Current Ratio of 1.27 indicates that FRE should not have too much problems paying its short term obligations.
FRE has a better Current ratio (1.27) than 73.91% of its industry peers.
FRE has a Quick Ratio of 1.27. This is a bad value and indicates that FRE is not financially healthy enough and could expect problems in meeting its short term obligations.
FRE's Quick ratio of 0.98 is fine compared to the rest of the industry. FRE outperforms 65.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
FRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 667.92%, which is quite impressive.
Measured over the past years, FRE shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.29% on average per year.
The Revenue for FRE has decreased by -32.87% in the past year. This is quite bad
The Revenue has been decreasing by -9.22% on average over the past years.
EPS 1Y (TTM)667.92%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%177.06%
Revenue 1Y (TTM)-32.87%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%-0.85%
3.2 Future
FRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.42% yearly.
Based on estimates for the next years, FRE will show a small growth in Revenue. The Revenue will grow by 3.99% on average per year.
EPS Next Y10.09%
EPS Next 2Y10.97%
EPS Next 3Y9.91%
EPS Next 5Y8.42%
Revenue Next Year5.4%
Revenue Next 2Y5.12%
Revenue Next 3Y4.8%
Revenue Next 5Y3.99%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
FRE is valuated correctly with a Price/Earnings ratio of 13.24.
Based on the Price/Earnings ratio, FRE is valued a bit cheaper than the industry average as 73.91% of the companies are valued more expensively.
FRE is valuated cheaply when we compare the Price/Earnings ratio to 28.79, which is the current average of the S&P500 Index.
FRE is valuated correctly with a Price/Forward Earnings ratio of 12.03.
Compared to the rest of the industry, the Price/Forward Earnings ratio of FRE indicates a somewhat cheap valuation: FRE is cheaper than 73.91% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of FRE to the average of the S&P500 Index (21.38), we can say FRE is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.24 | ||
| Fwd PE | 12.03 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FRE is on the same level as its industry peers.
FRE's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.04 | ||
| EV/EBITDA | 10.33 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.31
PEG (5Y)N/A
EPS Next 2Y10.97%
EPS Next 3Y9.91%
5. Dividend
5.1 Amount
FRE has a Yearly Dividend Yield of 2.51%.
FRE's Dividend Yield is a higher than the industry average which is at 2.81.
Compared to an average S&P500 Dividend Yield of 2.47, FRE has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.51% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
5.3 Sustainability
DP0%
EPS Next 2Y10.97%
EPS Next 3Y9.91%
FRA:FRE (4/25/2025, 7:00:00 PM)
39.85
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners42.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap22.45B
Analysts83.33
Price Target46.23 (16.01%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.51% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.58%
Min EPS beat(2)-3.48%
Max EPS beat(2)12.64%
EPS beat(4)2
Avg EPS beat(4)2.98%
Min EPS beat(4)-6.22%
Max EPS beat(4)12.64%
EPS beat(8)4
Avg EPS beat(8)-55.41%
EPS beat(12)5
Avg EPS beat(12)-44.47%
EPS beat(16)7
Avg EPS beat(16)-33.27%
Revenue beat(2)2
Avg Revenue beat(2)1.41%
Min Revenue beat(2)0.41%
Max Revenue beat(2)2.4%
Revenue beat(4)2
Avg Revenue beat(4)-0.07%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)2.4%
Revenue beat(8)2
Avg Revenue beat(8)-0.47%
Revenue beat(12)4
Avg Revenue beat(12)-0.31%
Revenue beat(16)5
Avg Revenue beat(16)-0.22%
PT rev (1m)7.31%
PT rev (3m)15.07%
EPS NQ rev (1m)-2.89%
EPS NQ rev (3m)-14.57%
EPS NY rev (1m)0.26%
EPS NY rev (3m)-1.65%
Revenue NQ rev (1m)-3.95%
Revenue NQ rev (3m)-0.6%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.03%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.24 | ||
| Fwd PE | 12.03 | ||
| P/S | 1.03 | ||
| P/FCF | 15.04 | ||
| P/OCF | 9.29 | ||
| P/B | 1.15 | ||
| P/tB | 11.03 | ||
| EV/EBITDA | 10.33 |
EPS(TTM)3.01
EY7.55%
EPS(NY)3.31
Fwd EY8.32%
FCF(TTM)2.65
FCFY6.65%
OCF(TTM)4.29
OCFY10.76%
SpS38.76
BVpS34.7
TBVpS3.61
PEG (NY)1.31
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.08% | ||
| ROE | 2.41% | ||
| ROCE | 5.17% | ||
| ROIC | 2.58% | ||
| ROICexc | 2.89% | ||
| ROICexgc | 6.68% | ||
| OM | 8.18% | ||
| PM (TTM) | 2.16% | ||
| GM | 24.63% | ||
| FCFM | 6.83% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
F-Score6
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 9.1 | ||
| Debt/EBITDA | 3.61 | ||
| Cap/Depr | 76.66% | ||
| Cap/Sales | 4.23% | ||
| Interest Coverage | 4.31 | ||
| Cash Conversion | 80.74% | ||
| Profit Quality | 316.77% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | 1.85 |
F-Score6
WACC7.39%
ROIC/WACC0.35
Cap/Depr(3y)72.62%
Cap/Depr(5y)76.65%
Cap/Sales(3y)6.17%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)667.92%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%177.06%
EPS Next Y10.09%
EPS Next 2Y10.97%
EPS Next 3Y9.91%
EPS Next 5Y8.42%
Revenue 1Y (TTM)-32.87%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%-0.85%
Revenue Next Year5.4%
Revenue Next 2Y5.12%
Revenue Next 3Y4.8%
Revenue Next 5Y3.99%
EBIT growth 1Y-8.69%
EBIT growth 3Y-24.73%
EBIT growth 5Y-17.37%
EBIT Next Year67.09%
EBIT Next 3Y24.71%
EBIT Next 5Y15.45%
FCF growth 1Y-54.6%
FCF growth 3Y-21.04%
FCF growth 5Y-3.73%
OCF growth 1Y-45.36%
OCF growth 3Y-21.94%
OCF growth 5Y-10.74%